Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > There are probably many hoping that--

<< Previous

Bullboard Posts

Next >>

Comment by Scorpio2on Dec 06, 2021 4:44pm

504 Views

Post# 34203808

RE:RE:RE:RE:RE:RE:RE:RE:There are probably many hoping that--

Rumpl and Menoalittle...I don't see the Theralase warrants ever being converted into the warrants of an acquirer. Just way too complex to calculate and create something that's fair and comparable in terms of value and profit potential to the Theralase warrants. Best is still to convert the warrants into Theralase common (for those that can i.e. Canadian investors) and then take cash and/or common stock of the acquirer on any offer.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"